K-numberK243226
Device nameUltrasound Imaging System (LU700 Series); Ultrasound Imaging System (128 Series); Ultrasound Imaging System (LX Series)
ApplicantLeltek, Inc.
Product codeIYN
Device classClass II
Decision dateMay 8, 2025
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Ultrasound Imaging System is a portable, software-based ultrasound device that runs on commercial mobile devices (tablets/smartphones) and communicates wirelessly via Wi-Fi. It includes three product series (LX, 128, LU700) with multiple transducer models and supports B-mode, M-mode, Doppler, and color flow imaging for a broad range of diagnostic ultrasound applications including fetal, cardiac, musculoskeletal, and interventional guidance.

Technological characteristics

The LX Series introduces dual-headed probes (LX128LC, LX128LP, LX192LC) combining linear, convex, and phased-array elements in a single probe housing. The 128 and LU700 Series retain single-headed probe designs. All three series use the same core software architecture, wireless communication via IEEE 802.11 a/b/g/n, Li-ion rechargeable batteries, and comply with IEC 60601-1 Edition 3.2 and IEC 60601-1-2 Edition 4.1 safety standards.

Test standards cited

IEC 60601-1 Edition 3.2 (2020), IEC 60601-1-2 Edition 4.1 (2020), IEC 60601-1-6 (usability), IEC 60601-2-37 (ultrasonic diagnostic equipment), IEC 62133-2 (battery safety), AIUM/NEMA UD 2 & UD 3, ISO 10993 series (biocompatibility), ISO 14971 (risk management), ISO 62304 (software lifecycle), and ISO 13485 (quality management).

Substantial equivalence argument

The LX Series maintains identical software, cover materials, and transducer specifications as the predicate 128 Series while replacing a single PCB with a dual-headed probe design. Acoustic output testing, biocompatibility, and cleaning/disinfection effectiveness all meet FDA requirements and show no adverse effects. The same clinical applications apply across all three series. Since the technology, safety standards compliance, and operating modes are established and proven in the predicate device, the addition of this alternative probe form factor with equivalent performance and specifications creates substantial equivalence without requiring additional clinical testing.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →